Japanese encephalitis
~~~~~~~~~~~~~~~~~
i) agent: Japanese encephalitis virus( RNA virus).
ii) transmission: the bite of an infected mosquito, primarily Culex species.
mosquito; carrier of Japanese encephalitis virus(Culex tritaeniorhynchus)
---------- Department of Medical Entomology, NIID, Japan
---------- Department of Medical Entomology, NIID, Japan
iii) Disease: a few than 1% of human develop the encephalitis. Most peoples
------ are symptom-free. Case–fatality ratio is around 20%–30%.
------ Among survivors, 30%–50% may have significant neurological sequelae.
iv) Incidence of Japanese encephalitis:
----- In Japan, fewer than 10 patients/ year.
----- This virus is the most common cause of encephalitis in Asia,
----- occurring throughout most of Asia and parts of the western Pacific.
----- The virus has not been locally transmitted in Africa, Europe, or USA.
------ Centers for Disease Control and Prevention -------
----------- where mosquito bites are there ,
-----------Japanese encephalitis vaccine( 3 times; 0, 1~4 weeks, 1 year) should
----------- be administered.
Inactivated Vero Cell Culture-Derived JE Vaccine
Any questions;
Keiji Hagiwara, MD keijihagiwara@gmail.com